Subpulmonary Stenosis Overview

Save information for later
Sign Up

Learn About Subpulmonary Stenosis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Subpulmonary Stenosis Local Doctors?
Laura J. Olivieri
Elite in Subpulmonary Stenosis
Pediatric Cardiology
Elite in Subpulmonary Stenosis
Pediatric Cardiology

Pediatric Cardiology In Sewickley

2599 Wexford Bayne Road, 
Sewickley, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Laura Jean Olivieri, MD, is a board-certified Pediatric Cardiologist and the Director of Noninvasive Cardiac Imaging at Children's Hospital Pittsburgh, and an Associate Professor of Pediatrics at University of Pittsburgh. She graduated from University of Chicago Pritzker School of Medicine and completed her pediatric residency at Brown University in Providence, RI, where she also was invited to stay for a chief year. She completed her training in pediatric cardiology at Children's National Medical Center in Washington, DC following by a year in advanced cardiac imaging at the National Heart, Lung and Blood Institute specializing in cardiovascular magnetic resonance imaging. She is expert in transthoracic and transesophageal echocardiography, cardiac MRI and cardiac CT. She is also considered a leader in the field of 3-dimensional reconstruction of congenital heart defects from 3D imaging, and in adapting MRI methods to babies and children. She is most interested in improving image acquisition using MRI and echocardiographic in 3D printing of heart models and has compiled a successful grant portfolio to that end. She also serves as Principal Investigator for an R01 to investigate application of cardiac MRI and Interventional Cardiac Magnetic Resonance on the care of pediatric heart transplant patients. This is a 4.5 million dollar, 5-year contract aimed at using CMR to guide interventional cardiac catheterization procedures, using less sedation for diagnostic CMR procedures and to advance diagnostic CMR capabilities to use less invasive testing. Dr. Olivieri is rated as an Elite provider by MediFind in the treatment of Subpulmonary Stenosis. Her top areas of expertise are Subpulmonary Stenosis, Coarctation of the Aorta, Tetralogy of Fallot, Heart Transplant, and Angioplasty.

Elite in Subpulmonary Stenosis
Pediatric Cardiology | Pediatrics
Elite in Subpulmonary Stenosis
Pediatric Cardiology | Pediatrics
111 Michigan Ave Nw, W3.5, 600, 
Washington, DC 
Languages Spoken:
English, Cantonese
Accepting New Patients

Yue-hin Loke is a Pediatric Cardiologist and a Pediatrics provider in Washington, Washington, D.c.. Dr. Loke is rated as an Elite provider by MediFind in the treatment of Subpulmonary Stenosis. His top areas of expertise are Tetralogy of Fallot, Subpulmonary Stenosis, Pulmonary Atresia, Coarctation of the Aorta, and Heart Transplant. Dr. Loke is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Subpulmonary Stenosis
Pediatric Cardiology | Pediatrics | Intensive Care Medicine
Advanced in Subpulmonary Stenosis
Pediatric Cardiology | Pediatrics | Intensive Care Medicine

Ucsf Pediatrics Associates

505 Parnassus Ave, 
San Francisco, CA 
Languages Spoken:
English

Scott Soifer is a Pediatric Cardiologist and a Pediatrics provider in San Francisco, California. Dr. Soifer is rated as an Advanced provider by MediFind in the treatment of Subpulmonary Stenosis. His top areas of expertise are Truncus Arteriosus, Subpulmonary Stenosis, Ventricular Septal Defects, and Familial Dysautonomia.

What are the latest Subpulmonary Stenosis Clinical Trials?
Mechanistic Clinical Trial of Beta-Blocker Administration For Reactivating Cardiomyocyte Division In Tetralogy of Fallot

Summary: Heart failure is a common long-term complication in patients with congenital heart disease (CHD). Medical treatments to promote regeneration of new healthy heart muscle cells have the potential to provide new heart failure treatments for these patients. The development of such therapies is limited by the poor understanding of the ways in which heart muscles grow after birth. Investigators have lea...

Match to trials
Find the right clinical trials for you in under a minute
Get started